What's happening at Aignosis, and what's coming next.
Funding, partnerships, recognition, and a running count of the thing that actually matters: how many children have been screened.
As featured in
News & milestones.
- 202401

Founded in Jaipur
By Raksheet Jain and Divyansh Mangal. Earlier incubated at IIM Ahmedabad Ventures. Backed by angels including Rajneesh Bhandari and Amit Jain.
- 202502

Featured, Shark Tank India, Season 4
Secures ₹1 crore for 8% equity from Aman Gupta, Peyush Bansal and Varun Dua.
- 03

Recognition: BFI Europe immersion programme
Selected among the top 5 healthcare startups for a three-week market-access programme in Europe.
- 04

Selected, Nikhil Kamath's WTFund, second cohort
Chosen from thousands of applicants nationwide, with up to ₹20 lakh in grant funding and mentorship.
- 05

Selected, Google for Startups Accelerator: AI First
One of 20 startups chosen nationally from over 1,600 applicants.
- 06

Seed round: ₹4 crore led by Antler and Nikhil Kamath
Company moves from validation into scaled commercial and government deployment.
- 202607

CDSCO Class B certification completed
Aignosis moves from regulatory validation into commercial operations.
- 08

Partnership: Mankind Pharma
Nearly 1,300 Mankind medical representatives begin running Aignosis screening camps with paediatricians nationwide.
- 09

Partnership: Apollo Shines
Aignosis begins operations with Apollo Shines, the Apollo group's school infirmary division, across roughly 125 schools.
Innovation only matters when it reaches the child who needs it most.
Children Screened
Government PHCs
Screening Camps
Referrals
Psych-Evaluation Calls
Every number here represents a family that got an answer sooner than they would have otherwise. Real, anonymized family stories from the impact report live on our Parents page.
The road to 100,000.
Aignosis is aiming for at least 100,000 total screenings by the end of FY26-27, up from 8,000+ today, alongside expansion into Punjab, NCR, Haryana, Tamil Nadu, Jharkhand, Karnataka and Maharashtra, and a parallel push toward US FDA and European CE certification.
Get it before the press does.
Funding news, new partnerships, and what we're learning as we scale, straight to your inbox, no more than once a month.



